Journalists to discuss scientific challenges in Stevens lecture

The Center for Science Writings at Stevens Institute of Technology will host three pre-eminent science journalists to discuss "Science's Greatest Challenges." The event is free and open to the public and will be held on the Stevens campus, Wednesday, February 8, 5:00 to 6:30 p.m. in the Bissinger Room, fourth floor of the Wesley J. Howe Center. The expert panel includes Sharon Begley, science columnist, The Wall Street Journal; John Rennie, editor-in-chief, Scientific American; and Steven Petranek, editor-in-chief, Discover magazine. John Horgan, Director of the Stevens Center for Science Writings, will moderate the discussion.

The panel will cover scientific challenges such as the origin of the universe, life and human consciousness as well as immense practical problems such as AIDS and other diseases, global warming and natural disasters. As a cultural institution dependent on public confidence and support, science must also cope with the challenge of widespread misunderstanding and distrust of scientific explanations of nature and advances such as stem cells and cloning.


Contact: Stephanie Mannino
Stevens Institute of Technology

Page: 1

Related biology news :

1. Journalists can register now for ECCO 14 -- the European Cancer Conference
2. Leading drug discovery and biotechnology scientists and experts discuss latest advancements
3. Scientists will discuss creating a culture of sustainability February 19 at AAAS
4. Protecting US crops from terrorist attack to be discussed at 2007 AAAS Annual Meeting
5. Neuroscientist Robert Sapolsky will discuss stress, health, Feb. 17 at AAAS meeting
6. Stanford professor to discuss the ups and downs of team science
7. Paleontologists to discuss gap fossils that link fish and land animals
8. Climate scientists to discuss the chilling consequences of nuclear war
9. Leading scientists gather to discuss developments in infectious disease research
10. Winning the oil endgame in America to be discussed at NJIT forum
11. Scientists discuss new frontiers in single-molecule research at American Chemical Society

Post Your Comments:

(Date:6/15/2016)... ALBANY, New York , June 15, 2016 ... published a new market report titled "Gesture Recognition Market ... Trends and Forecast, 2016 - 2024". According to the ... at USD 11.60 billion in 2015 and is ... and reach USD 48.56 billion by 2024.  ...
(Date:6/9/2016)... -- Paris Police Prefecture ... to ensure the safety of people and operations in several ... tournament Teleste, an international technology group specialised in ... that its video security solution will be utilised by ... safety across the country. The system roll-out is scheduled for ...
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
Cached News: